Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3G4G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,098
Award facts
- Contract value 100% obligated
- $13,098.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,098.06 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) on January 30, 2026, with a completion deadline of February 2, 2026. The contract utilizes firm fixed-price pricing and carries no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a critical federal medical procurement vendor. The company supplies an extensive portfolio of pharmaceutical products across multiple therapeutic domains to military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies. As a non-set-aside contractor, AmerisourceBergen has consistently demonstrated capability to meet federal procurement requirements through open competition, with contract awards ranging from small-value transactions to substantial orders exceeding $45,000, positioning the company as a key supplier within the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F3G4G?
SPE2DR26F3G4G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F3G4G worth?
The government has obligated $13,098 on SPE2DR26F3G4G.
Is contract SPE2DR26F3G4G an order under another contract?
Yes. SPE2DR26F3G4G is a delivery order under SPE2DR25D3001, an indefinite delivery contract.
Was contract SPE2DR26F3G4G competed?
The extent of competition for SPE2DR26F3G4G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award